Atricure (ATRC) P/E (2011 - 2026)
Atricure (ATRC) P/E from Mar 31, 2011 to Jun 3, 2026. The TTM Atricure (ATRC) P/E is -283.30. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Atricure (ATRC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -283.30 | +65.45% |
| 2025 | -171.23 | +414.61% |
| 2024 | -33.27 | -50.98% |
| 2023 | -67.88 | -283.87% |
| 2022 | 36.92 | -47.98% |
| 2021 | 70.96 | -241.75% |
| 2020 | -50.06 | +37.67% |
| 2019 | -36.36 | -29.85% |
| 2018 | -51.83 | +175.39% |
| 2017 | -18.82 | +4.16% |
| 2016 | -18.07 | -26.64% |
| 2015 | -24.63 | -27.19% |
| 2014 | -33.83 | +5.85% |
| 2013 | -31.96 | +113.39% |
| 2012 | -14.98 | -71.57% |
| 2011 | -52.67 | N/A |
Comparison Atricure (ATRC) P/E with competitors
Atricure (ATRC) P/E is -283.30.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -100.08% |
| EMBC | Embecta Corp | 1.73 | -100.61% |
| SOLV | Solventum Corp | 9.19 | -103.24% |
| ZJYL | Jin Medical International Ltd | 14.31 | -105.05% |
| PDEX | Pro-Dex Inc (co) | 17.38 | -106.14% |
| UTMD | Utah Medical Products Inc | 19.32 | -106.82% |
| RMD | Resmed Inc | 19.77 | -106.98% |
| MMSI | Merit Medical Systems Inc | 26.66 | -109.41% |
| ALGN | Align Technology Inc | 27.22 | -109.61% |
| COO | Cooper Companies Inc | 29.86 | -110.54% |
| STVN | Stevanato Group Spa | 29.88 | -110.55% |
| HOLX | Hologic Inc | 30.86 | -110.89% |
| LMAT | Lemaitre Vascular Inc | 34.86 | -112.30% |
| ALC | Alcon Inc | 40.20 | -114.19% |
| WST | West Pharmaceutical Services Inc | 41.29 | -114.58% |
| BDX | Becton Dickinson & Company | 44.61 | -115.75% |
| NEPH | Nephros Inc | 49.38 | -117.43% |
| ISRG | Intuitive Surgical Inc | 49.96 | -117.63% |
| NVST | Envista Holdings Corp | 56.43 | -119.92% |
| BAX | Baxter International Inc | 63.44 | -122.39% |
| ICUI | ICU Medical Inc | 74.28 | -126.22% |
| RGEN | Repligen Corp | 123.98 | -143.76% |
| NNNN | Anbio Biotechnology - Class A | 223.63 | -178.94% |
| WRBY | Warby Parker Inc - Class A | 292.87 | -203.38% |